This website uses cookies to enhance the user experience.
SOFTOX SOLUTIONS AS

SOFTOX SOLUTIONS AS998 516 390

Research
Limited company
Martin Linges vei 25 1364 FORNEBU, Norge

SOFTOX SOLUTIONS AS

Home - SoftOx Solutions
SoftOx is aiming to solve major health challenges with a non-toxic and highly effective antiseptic technology.

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Links

Organization

CEO
Chairman of the board
Years since formation
13 years
since Jun 21, 2012
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
1,951,253,942
1 share class
Total number of shareholders
1916
146 companies, 1,770 persons
Belongs to group of

Financials

Total operating income 2023
2,185,793
NOK
Annual total result 2023
-45,550,205
NOK
Total equity 2023
13,095,638
NOK
Last update: Apr 9, 2025

Management

Management / administration

NameRoleShares
Managing Director/CEO
4.37 %
indirectly

Board

NameRoleShares
Board Member-
Chairman-
Deputy Chair-
ResignedBoard Member-
ResignedBoard Member-

Others

NameRoleShares
Auditor-
E
ECIT INTUNOR AS
Accountant-

Top 10 individual shareholders

NameRoleShares
-
14.1 %
indirectly
-
13.61 %
indirectly
-
8.13 %
indirectly
-
6.91 %
indirectly
-
5.12 %
indirectly
Managing Director/CEO
4.37 %
indirectly
-
2.37 %
indirectly
PH
-
2.03 %
indirectly
-
1.83 %
directly
-
1.79 %
directly
Last update: Jun 10, 2025

Ownership

Company shareholders

NameShare classTotal number of sharesShare
P
PRO AS
NO0010811961
265,562,550
13.61 %
J
J G INVEST AS
NO0010811961
239,412,833
12.27 %
O
OSLO NÆRINGSUTVIKLING AS
NO0010811961
158,668,670
8.13 %
H
HAREFRØKEN INVEST AS
NO0010811961
131,643,699
6.75 %
M
MYRLID AS
NO0010811961
100,000,000
5.12 %
B
BONICA AS
NO0010811961
85,178,282
4.37 %
A
ALMHAUG BOLIG AS
NO0010811961
79,150,064
4.06 %
NO0010811961
48,504,227
2.49 %
S
STIFTELSEN UNI
NO0010811961
47,655,000
2.44 %
L
LOYD AS
NO0010811961
46,301,000
2.37 %
A
AUBERT INVEST AS
NO0010811961
36,965,745
1.89 %
NO0010811961
35,696,525
1.83 %
NO0010811961
35,000,000
1.79 %
N
NORDNET LIVSFORSIKRING AS
NO0010811961
32,201,732
1.65 %
W
WL-02 HOLDING AS
NO0010811961
30,657,119
1.57 %
H
HOLTA & CO. AS
NO0010811961
28,497,844
1.46 %
NO0010811961
26,394,786
1.35 %
G
GH HOLDING AS
NO0010811961
25,322,329
1.3 %
G
GEMALLO AS
NO0010811961
24,983,572
1.28 %
NO0010811961
18,618,771
0.95 %
NO0010811961
17,327,549
0.89 %
NO0010811961
16,250,000
0.83 %
NO0010811961
14,876,267
0.76 %
W
WL-01 HOLDING AS
NO0010811961
14,000,000
0.72 %
R
RESULTING AS
NO0010811961
13,168,215
0.67 %
A
ARJO BYGG AS
NO0010811961
13,000,000
0.67 %
S
STORHAUGEN INVEST AS
NO0010811961
10,010,279
0.51 %
NO0010811961
10,000,050
0.51 %
NO0010811961
9,900,000
0.51 %
NO0010811961
9,309,283
0.48 %
NO0010811961
9,100,000
0.47 %
NO0010811961
8,520,185
0.44 %
NO0010811961
7,010,000
0.36 %
NO0010811961
6,801,000
0.35 %
R
RUTEN AS
NO0010811961
6,354,000
0.33 %
NO0010811961
5,736,580
0.29 %
NO0010811961
5,306,200
0.27 %
NO0010811961
5,100,863
0.26 %
NO0010811961
4,574,148
0.23 %
G
GEHITO AS
NO0010811961
4,014,146
0.21 %
NO0010811961
3,710,714
0.19 %
NO0010811961
3,588,293
0.18 %
NO0010811961
3,500,000
0.18 %
NO0010811961
3,393,073
0.17 %
P
PERFORMAX AS
NO0010811961
3,267,386
0.17 %
H
HERMOD FARMS AS
NO0010811961
3,227,891
0.17 %
NO0010811961
3,196,201
0.16 %
NO0010811961
3,101,000
0.16 %
NO0010811961
3,017,700
0.15 %
V
VULGATA AS
NO0010811961
3,000,000
0.15 %
NO0010811961
3,000,000
0.15 %
NO0010811961
3,000,000
0.15 %
NO0010811961
3,000,000
0.15 %
NO0010811961
3,000,000
0.15 %
NO0010811961
2,930,093
0.15 %
NO0010811961
2,900,000
0.15 %
NO0010811961
2,865,000
0.15 %
NO0010811961
2,800,000
0.14 %
NO0010811961
2,750,000
0.14 %
NO0010811961
2,700,000
0.14 %
NO0010811961
2,700,000
0.14 %
S
SOLVIDA AS
NO0010811961
2,551,775
0.13 %
H
HJELKREM INVEST AS
NO0010811961
2,513,000
0.13 %
B
BOATSWAIN AS
NO0010811961
2,500,000
0.13 %
NO0010811961
2,478,828
0.13 %
NO0010811961
2,400,000
0.12 %
NO0010811961
2,369,063
0.12 %
NO0010811961
2,300,000
0.12 %
NO0010811961
2,211,521
0.11 %
A
AS KIRKEGATEN 9
NO0010811961
2,197,349
0.11 %
NO0010811961
2,164,190
0.11 %
D
DINGE INVEST AS
NO0010811961
2,130,591
0.11 %
NO0010811961
2,125,623
0.11 %
NO0010811961
2,075,004
0.11 %
NO0010811961
2,028,500
0.1 %
NO0010811961
2,000,000
0.1 %
NO0010811961
2,000,000
0.1 %
NO0010811961
2,000,000
0.1 %
NO0010811961
2,000,000
0.1 %
NO0010811961
2,000,000
0.1 %
NO0010811961
2,000,000
0.1 %
T
TH DAHL AS
NO0010811961
2,000,000
0.1 %
NO0010811961
2,000,000
0.1 %
NO0010811961
1,948,789
0.1 %
K
KOMMODE HOLDING AS
NO0010811961
1,892,980
0.1 %
NO0010811961
1,779,577
0.09 %
C
COLLEGIUM MANAGEMENT AS
NO0010811961
1,742,262
0.09 %
NO0010811961
1,727,527
0.09 %
NO0010811961
1,717,575
0.09 %
NO0010811961
1,672,812
0.09 %
NO0010811961
1,649,073
0.08 %
NO0010811961
1,623,000
0.08 %
NO0010811961
1,602,441
0.08 %
NO0010811961
1,581,546
0.08 %
L
L B HOLDING AS
NO0010811961
1,560,491
0.08 %
NO0010811961
1,500,000
0.08 %
NO0010811961
1,500,000
0.08 %
T
TREJO INVEST AS
NO0010811961
1,500,000
0.08 %
NO0010811961
1,485,476
0.08 %
NO0010811961
1,470,951
0.08 %

Shares owned by the SOFTOX SOLUTIONS AS

NameShare classTotal number of sharesShare
S
SOFTOX WOUND & SKIN CARE AS
Ordinary shares
400
100 %
S
SOFTOX DEFENSE SOLUTIONS AS
Ordinary shares
30
100 %
Last update: Jun 2, 2025

Group structure

  • Total operating income 2023: NOK 2,185,793
    Operating profit 2023: NOK -41,967,859
    Employees: 0

Financials

in NOK

Summary

Year202320222021
Total operating income
2,185,793
5,983,776
6,019,466
Annual Total Result
-45,550,205
-68,579,760
-59,807,261
Total assets
89,043,294
114,760,391
141,219,926
Total liabilities
75,947,656
59,194,315
17,074,090
Total equity
13,095,638
55,566,076
124,145,836

P&L

Year202320222021
Total operating income
2,185,793
5,983,776
6,019,466
Total operating costs
44,153,652
94,839,905
85,079,011
Operating result
-41,967,859
-88,856,129
-79,059,545
Financial income/costs
-10,932,219
-1,749,109
-113,148
Profit before tax
-52,900,078
-90,605,238
-79,172,693
Total tax & extraordinary income/cost
-7,349,873
-22,025,478
-19,365,432
Annual Total Result
-45,550,205
-68,579,760
-59,807,261

Balance overview

Year202320222021
Total fixed assets
84,506,227
101,528,253
78,024,776
Total current assets
4,537,067
13,232,138
63,195,150
Total assets
89,043,294
114,760,391
141,219,926
Short term debt
30,358,767
18,505,426
17,074,090
Long term debt
45,588,889
40,688,889
0
Total liabilities
75,947,656
59,194,315
17,074,090
Contributed capital
13,095,638
55,566,076
124,145,836
Retained earnings
0
0
0
Total equity
13,095,638
55,566,076
124,145,836
Total equity and liabilities
89,043,294
114,760,391
141,219,926

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology